Clinical Trial Update: A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer [Phase 3]

View source ↗

Summary

A phase 3 trial comparing the combination of TC plus Bevacizumab to TC alone and to TAC in women with node-positive or high-risk node-negative, HER2-negative br…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• TAC
• TC

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED